Can I abruptly discontinue fluoxetine 60 mg daily and trazodone 150 mg at bedtime in this patient?

No, Do Not Abruptly Discontinue Either Medication

You should not abruptly discontinue fluoxetine 60 mg or trazodone 150 mg in this patient—both medications require gradual tapering to minimize withdrawal symptoms and other adverse effects.

Fluoxetine Discontinuation

Why Fluoxetine Can Be Stopped More Safely Than Other SSRIs

Fluoxetine has a uniquely long elimination half-life (several days to weeks when including its active metabolite norfluoxetine), which provides built-in protection against discontinuation syndrome 1. This pharmacokinetic property means that fluoxetine is the only SSRI that can potentially be stopped without a formal taper in many patients 2, 3.

Evidence for Fluoxetine Discontinuation

• A randomized controlled trial demonstrated that abrupt fluoxetine discontinuation was well-tolerated, with only mild, self-limited lightheadedness or dizziness in a small percentage of patients 2
• Comparative studies show fluoxetine-treated patients experience significantly fewer discontinuation symptoms than those on shorter-acting SSRIs like paroxetine, even with brief 3-5 day treatment interruptions 3
• However, the FDA label still recommends gradual dose reduction whenever possible to minimize discontinuation syndrome symptoms (nausea, sweating, dysphoric mood, irritability, agitation, dizziness, sensory disturbances, anxiety, confusion, headache) 1

Recommended Approach for Fluoxetine

Given the patient is on a high dose (60 mg):

• Gradual tapering is still recommended despite fluoxetine's protective half-life
• The long half-life means plasma concentrations decrease gradually over weeks after stopping, naturally minimizing withdrawal risk 1
• If tapering, reduce by 25-50% every 2-4 weeks (e.g., 60 mg → 40 mg → 20 mg → stop) 4
• Monitor for discontinuation symptoms: dizziness, sensory disturbances ("brain zaps"), anxiety, irritability, insomnia 5

Trazodone Discontinuation

Why Trazodone Requires Tapering

Trazodone absolutely requires gradual discontinuation—it should never be stopped abruptly 6. The FDA label explicitly warns about discontinuation syndrome with serotonergic antidepressants, including trazodone.

Discontinuation Syndrome Risk

Trazodone discontinuation can cause 6:

• Nausea, sweating, dysphoric mood
• Irritability, agitation, dizziness
• Sensory disturbances (paresthesias, electric shock sensations)
• Tremor, anxiety, confusion, headache
• Emotional lability, insomnia, hypomania
• Seizures (rare but possible)

Recommended Tapering Approach for Trazodone 150 mg

At this dose (which is in the therapeutic range for both insomnia and depression 7, 8):

1. Reduce by 25-50 mg every 1-2 weeks (e.g., 150 mg → 100 mg → 50 mg → stop)
2. Monitor closely for withdrawal symptoms, especially in the first 24-48 hours after each dose reduction
3. If withdrawal symptoms emerge, pause the taper or return to the previous dose, then slow the reduction rate 9, 10
4. Some patients may require more gradual tapering over months, particularly if they've been on the medication long-term 4, 11

Critical Clinical Considerations

Common Pitfalls to Avoid

1. Do not mistake withdrawal symptoms for relapse of the underlying condition 10, 11—withdrawal typically occurs within days of dose reduction and includes physical symptoms (dizziness, sensory disturbances, flu-like symptoms)
2. Do not assume fluoxetine's long half-life eliminates all risk—while protective, gradual reduction is still safer, especially at higher doses 1
3. Do not use the same tapering schedule for all patients—those on medications longer, at higher doses, or with prior withdrawal experiences need slower tapers 4, 11

Patient Education Before Discontinuation

Inform the patient that 6, 1, 9:

• Withdrawal symptoms are common (occurring in ~20-50% of patients) but usually mild and self-limited 10
• Symptoms typically last 1-2 weeks and resolve with medication reinstitution if needed
• They should report new symptoms immediately: dizziness, "brain zaps," anxiety, flu-like symptoms
• Missing doses can trigger withdrawal symptoms, so adherence during tapering is crucial

Monitoring During Tapering

• See the patient every 2-4 weeks during active tapering 11
• Assess for both withdrawal symptoms AND relapse of the underlying condition (depression/anxiety/insomnia)
• Be prepared to slow or pause the taper if symptoms emerge
• Consider using standardized scales to differentiate withdrawal from relapse

Special Circumstances Requiring Slower Tapering

Consider very gradual tapering (over months, potentially using liquid formulations for micro-dosing) if 4, 11:

• Long duration of treatment (>1 year)
• Previous difficulty stopping antidepressants
• History of severe withdrawal symptoms
• Higher doses
• Concurrent use of multiple serotonergic agents

The safest approach is to taper both medications gradually over several weeks to months, with close monitoring and patient education about expected withdrawal symptoms versus relapse.